![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 2, 1016-1023, January 14, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Arrestin1 Ser-412 Phosphorylation Is a Mechanism for Desensitization of ERK Activation by G
i-coupled Receptors*



¶||**
From the
Department of Medicine, Division of Endocrinology and Metabolism and the
Department of Reproductive Medicine, University of California, San Diego, La Jolla, California 92093, the ¶Veterans Affairs Hospital, Research Service, San Diego, California 92161, and ||The Whittier Diabetes Institute, La Jolla, California 92037
-Arrestin1 is an adapter/scaffold for many G protein-coupled receptors during mitogen-activated protein kinase signaling. Phosphorylation of
-arrestin1 at position Ser-412 is a regulator of
-arrestin1 function, and in the present study, we showed that insulin led to a time- and dose-dependent increase in
-arrestin1 Ser-412 phosphorylation, which blocked isoproterenol- and lysophosphatidic acid-induced Ser-412 dephosphorylation and impaired ERK signaling by these G protein-coupled receptor ligands. Insulin treatment also led to accumulation of Ser-412-phosphorylated
-arrestin1 at the insulin-like growth factor 1 receptor and prevented insulin-like growth factor 1/Src association. Insulin-induced Ser-412 phosphorylation was partially dependent on ERK as treatment with the MEK inhibitor PD98059 inhibited the insulin effect (62% reduction, p = 0.03). Inhibition of phosphatidylinositol 3-kinase by wortmannin did not have a significant effect (9% reduction, p = 0.41). We also found that the protein phosphatase 2A (PP2A) was in a molecular complex with
-arrestin1 and that the PP2A inhibitor okadaic acid increased Ser-412 phosphorylation. Concomitant addition of insulin and okadaic acid did not produce an additive effect on Ser-412 phosphorylation, suggesting a common mechanism. Small t antigen specifically inhibited PP2A, and in HIRcB cells expressing small t antigen,
-arrestin1 Ser-412 phosphorylation was increased, and insulin had no further effect. Insulin treatment caused increased
-arrestin1 Ser-412 phosphorylation, which blocked mitogen-activated protein kinase signaling and internalization by
-arrestin1-dependent receptors with no effect on
-adrenergic receptor Gs-mediated cAMP production. These findings provide a new mechanism for insulin-induced desensitization of ERK activation by G
i-coupled receptors.
Received for publication, April 2, 2004 , and in revised form, October 12, 2004.
* This work was supported by National Institutes of Health Grant K08 DK65127-01 (to C. J. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Dept. of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-6073. Tel.: 858-534-6651; Fax: 858-534-6653; E-mail: jolefsky{at}ucsd.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Lee, S. Bhatt, A. Shukla, R. W. Desnoyer, S. P. Yadav, M. Kim, S.-H. Jang, and S. S. Karnik Site-specific Cleavage of G Protein-coupled Receptor-engaged {beta}-Arrestin: INFLUENCE OF THE AT1 RECEPTOR CONFORMATION ON SCISSILE SITE SELECTION J. Biol. Chem., August 1, 2008; 283(31): 21612 - 21620. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sonoda, T. Imamura, T. Yoshizaki, J. L. Babendure, J.-C. Lu, and J. M. Olefsky {beta}-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic {beta} cells PNAS, May 6, 2008; 105(18): 6614 - 6619. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Galownia, K. Kushiro, Y. Gong, and A. R. Asthagiri Selective Desensitization of Growth Factor Signaling by Cell Adhesion to Fibronectin J. Biol. Chem., July 27, 2007; 282(30): 21758 - 21766. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Swift, M. R. Schwarb, K. A. Mihlbachler, and S. B. Liggett Pleiotropic beta-Agonist-Promoted Receptor Conformations and Signals Independent of Intrinsic Activity Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 236 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Buchanan, D. L. Gorden, P. Matta, Q. Shi, L. M. Matrisian, and R. N. DuBois Role of beta-arrestin 1 in the metastatic progression of colorectal cancer PNAS, January 31, 2006; 103(5): 1492 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Van Kanegan, D. G. Adams, B. E. Wadzinski, and S. Strack Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and Akt J. Biol. Chem., October 28, 2005; 280(43): 36029 - 36036. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Lefkowitz and S. K. Shenoy Transduction of Receptor Signals by {beta}-Arrestins Science, April 22, 2005; 308(5721): 512 - 517. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |